Lantern Pharma Inc. - ESG Rating & Company Profile powered by AI
If you work at Lantern Pharma Inc. and you wish to licence your Sustainability aseessment, please contact us. The report of Lantern Pharma Inc. was prepared by All Street Sevva using leading AI. Other corporations in the scoring industry group for Lantern Pharma Inc. are displayed.
Lantern Pharma Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 5.3, social score of 8.0 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
| 224 | Lantern Pharma Inc. | 7.1 | High |
| 224 | Celularity Inc | 7.1 | High |
| 224 | Bilcare Ltd | 7.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lantern Pharma Inc. have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose current and historical energy intensity?
Sign up for free to unlockDoes Lantern Pharma Inc. report the average age of the workforce?
Sign up for free to unlockDoes Lantern Pharma Inc. reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose cybersecurity risks?
Sign up for free to unlockDoes Lantern Pharma Inc. offer flexible work?
Sign up for free to unlockDoes Lantern Pharma Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lantern Pharma Inc. conduct supply chain audits?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lantern Pharma Inc. conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose water use targets?
Sign up for free to unlockDoes Lantern Pharma Inc. have careers partnerships with academic institutions?
Sign up for free to unlockDid Lantern Pharma Inc. have a product recall in the last two years?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose incidents of discrimination?
Sign up for free to unlockDoes Lantern Pharma Inc. allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lantern Pharma Inc. issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose parental leave metrics?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lantern Pharma Inc. support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lantern Pharma Inc. reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lantern Pharma Inc. involved in embryonic stem cell research?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose its waste policy?
Sign up for free to unlockDoes Lantern Pharma Inc. report according to TCFD requirements?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose energy use targets?
Sign up for free to unlockDoes Lantern Pharma Inc. disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lantern Pharma Inc. have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lantern Pharma Inc.
These potential risks are based on the size, segment and geographies of the company.
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.